RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Results From LUMINOUS, a Global Real-World Study

PURPOSE: To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naive patients with neovascular age-related macular degeneration enrolled in LUMINOUS study. METHODS: This 5-year, prospective, multicenter, observational study recruited 30,138 adult patients (...

Descripción completa

Detalles Bibliográficos
Autores principales: Holz, Frank G., Figueroa, Marta S., Bandello, Francesco, Yang, Yit, Ohji, Masahito, Dai, Hong, Wykrota, Halina, Sharma, Sanjay, Dunger-Baldauf, Cornelia, Lacey, Sue, Macfadden, Wayne, Mitchell, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2020
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447127/
https://www.ncbi.nlm.nih.gov/pubmed/31764612
http://dx.doi.org/10.1097/IAE.0000000000002670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447127/
https://www.ncbi.nlm.nih.gov/pubmed/31764612
http://dx.doi.org/10.1097/IAE.0000000000002670

Ejemplares similares